Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release

- VivoRx, Inc.

The present invention relates to a new form of biocompatible materials (e.g., lipids, polycations, polysaccharides) which are capable of undergoing free radical polymerization, e.g., by using certain sources of light; methods of modifying certain synthetic and naturally occurring biocompatible materials to make polymerizable microcapsules containing biological material coated with said polymerizable materials, composites of said polymerizable materials, methods of making microcapsules and encapsulating biological materials therein, and apparatus for making microcapsules containing biological cells (particularly islets of Langerhans) coated with polymerizable alginate or with a composite thereof (e.g., alginate and PEG). The present invention also relates to drug delivery systems relating to the foregoing, as well as bioadhesives and wound dressings made utilizing the foregoing technology.

Skip to:  ·  Claims  ·  References Cited  · Patent History  ·  Patent History

Claims

1. A modified biocompatible material having the formula:

a) A is a biocompatible starting material selected from a polysaccharide, polycation, or lipid;
b) X is a moiety containing a carbon--carbon double bond or triple bond capable of undergoing free radical polymerization;
c) A and X are linked covalently through linkages selected from ester, ether, thioether, disulfide, amide, secondary amines, tertiary amines, direct C--C linkages, sulfate esters, sulfonate esters, phosphate esters, urethanes, or carbonates;
d) said modified biocompatible material forms covalent crosslinks when subjected to biocompatible, free radical polymerization producing conditions in aqueous media consisting essentially of water and solutes, or consisting essentially of water, solutes, and a biocompatible oil; and
e) A--X is produced in aqueous media consisting essentially of water and solutes.

2. A modified biocompatible material according to claim 1 wherein A is alginate.

3. A modified biocompatible material according to claim 1 wherein X is an alkenyl radical.

4. A modified biocompatible material according to claim 1 wherein A and X are linked covalently through an ester linkage.

5. A modified biocompatible material according to claim 1 wherein A is a polysaccharide selected from alginate, high M-content alginate, polymannuronic acid, polymannuronate, hyaluronic acid, chitosan, chitin, cellulose, starch, glycogen, guar gum, locust bean gum, dextran, levan, inulin, cyclodextran, agarose, xanthan gum, carageenan, heparin, pectin, gellan gum, or scleroglucan.

6. A modified biocompatible material according to claim 5 wherein said polysaccharide is sulfonated.

7. A modified biocompatible material according to claim 1 wherein A is a polycation selected from polyhistidine, polylysine, polyornithine, polyarginine, polyalanine-polylysine, poly(histidine, glutamic acid)-poyalanine-polyilysine, poly(phenylalanine, glutamic acid)-polyalanine-polylysine, poly(tyrosine, glutamic acid)-polyalanine-polylysine, collagen, gelatin; random copolymers of: arginine with tryptophan, tyrosine, or serine; glutamic acid with lysine; glutamic acid with lysine, ornithine; or mixtures of any two or more thereof.

8. A modified biocompatible material according to claim 1 wherein A is a lipid selected from phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, phosphatidylglycerol or dilaurylphosphatidic acid.

9. A modified biocompatible material according to claim 1 wherein said modified biocompatible material will undergo ionic polymerization in the presence of aqueous media, to form ionic crosslinks.

10. A modified biocompatible material according to claim 9 wherein said modified biocompatible material is alginate.

11. A crosslinked biocompatible material produced by subjecting said modified biocompatible material of claim 1 to ionic crosslinking and/or free radical polymerization conditions.

12. A modified biocompatible material according to claim 1 wherein said biocompatible oil is silicone oil.

13. A modified biocompatible material according to claim 1 having further covalently linked thereto Y, wherein Y is selected from alkylene glycols, polyalkylene glycols, or hydrophobic onium cations, wherein said modified biocompatible material has the formula

14. A modified biocompatible material according to claim 13 wherein A is a polysaccharide selected from alginate, high M-content alginate, polymannuronic acid, polymannuronate, hyaluronic acid, chitosan, chitin, cellulose, starch, glycogen, guar gum, locust bean gum, dextran, levan, inulin, cyclodextran, agarose, xanthan gum, carageenan, heparin, pectin, gellan gum, or scleroglucan.

15. A modified biocompatible material according to claim 14 wherein said polysaccharide is sulfonated.

16. A crosslinked biocompatible material produced by subjecting said modified biocompatible material of claim 13 to ionic crosslinking and/or free radical polymerization conditions.

17. A method for the free radical polymerization of biocompatible starting materials characterized by having a reactive functionality thereon, wherein said biocompatible starting materials are selected from polysaccharides, polycations, or lipids, said method comprising:

chemically modifying said biocompatible starting material in aqueous media consisting essentially of water and solutes with a reactive species capable of free radical polymerization, thereby creating a modified biocompatible material capable of forming covalent crosslinks; and
contacting said modified biocompatible material with a free radical initiating system under biocompatible, free radical producing conditions in aqueous media consisting essentially of water and solutes, or consisting essentially of water, solutes, and a biocompatible oil.

18. A method according to claim 17 wherein said reactive functionality is selected from hydroxyl, carboxyl, primary or secondary amine, aldehyde, ketone or ester groups.

19. A method according to claim 18 wherein said reactive species is selected from alkenoic acids or the corresponding acid chlorides or acid anhydrides, alkenols, alkenyl halides, or organometallic alkenyl compounds.

20. A method according to claim 19 wherein said reactive species is an alkenoic acid anhydride.

21. A method according to claim 19 wherein said reactive species is selected from acryloyl chloride, methacryloyl chloride, acrylic acid, methacrylic acid, acrylic anhydride, met hacrylic anhydride, allyl alcohol, allyl chloride, or vinyl magnesium bromide.

22. A method according to claim 17 wherein said radical initiating system comprises a photosensitizing agent and a cocatalyst.

23. A method according to claim 22 wherein said photosensitizing agent is a dye selected from ethyl eosin, eosin, erythrosin, riboflavin, fluorscein, rose bengal, methylene blue, or thionine, and said cocatalyst is triethanolamine, arginine, methyldiethanol amine, or triethylamine.

24. A method according to claim 22 wherein said free radical initiating system further comprises a comonomer.

25. A method according to claim 17 wherein said biocompatible starting material will undergo ionic polymerization in aqueous media, and wherein said modified biocompatible material will form both ionic and covalent crosslinks in aqueous media.

26. A method according to claims 17 wherein said biocompatible starting material is alginate.

27. A method according to claim 17 wherein said biocompatible oil is silicone oil.

28. A biocompatible gel produced by the method of claim 17.

29. A modified biocompatible material having the formula:

a) A is selected from phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, phosphatidylglycerol or dilaurylphosphatidic acid;
b) X is a moiety containing a carbon--carbon double bond or triple bond capable of undergoing free radical polymerization;
c) A and X are linked covalently through linkages selected from ester, ether, thioether, disulfide, amide, secondary amines, tertiary amines, direct C--C linkages, sulfate esters, sulfonate esters, phosphate esters, urethanes, or carbonates; and
d) said modified biocompatible material forms covalent crosslinks when subjected to biocompatible, free radical polymerization producing conditions in aqueous media consisting essentially of water and solutes, or consisting essentially of water, solutes, and a biocompatible oil.
Referenced Cited
U.S. Patent Documents
3332897 July 1967 Ray-Chaudhuri
4321117 March 23, 1982 Kaetsu et al.
4605691 August 12, 1986 Balazs et al.
4654233 March 31, 1987 Grant et al.
4778880 October 18, 1988 Symes et al.
4803168 February 7, 1989 Jarvis, Jr.
4806355 February 21, 1989 Goosen et al.
4861629 August 29, 1989 Nahm
5128326 July 7, 1992 Balazs et al.
Foreign Patent Documents
4128482 October 1979 JPX
Other references
  • PTO Translation at J54 128482, "A Microcapsule and a Method of Manufacturing It"., Oct. 1979. Braun et al., "The encapsulation of pancreatic islets. Investigation of insulin secretion and content in vitro" Biochim. Acta 44:143-147 (1995). Chang, "Artificial Cells in Medicine and Biotechnology" Humana Press, 10:4-24 (1984). Decker and Moussa, "Real-Time Kinetic Study of Laser-Induced Polymerization" Macromolecules 22:4455-4461 (1989). Eaton, David F., "Dye Sensitized Photopolymerization" Advances in Photochemistry 13:427-487 (1986). Harris et al., "Synthesis and Characterization of Poly(ethylene Glycol) Derivatives" J. Polym. Sci., Polym. Chem. Ed. 22:341-352 (1984). Mathias et al., "Synthesis and Polymerization of Mono-and Divinyl Ethers of Oligooxyethylenes" J. Polym. Sci., Polym. Lett. Ed. 20:473-479 (1982). Moe et al., "Covalently cross-linked sodium aliginate beads" Food Hydrocolloids 5:119-123 (1991). Morrison and Boyd, "Organic Chemistry" Organic Chemistry, Allyn and Bacon, pp. 756-757 (1973). Wu, David S., "Optical-scanner design impacts rapid laser prototyping" Laser Focus World pp. 99-106 (Nov. 1990). Abuchowski et al., "Alteration of Immunological Properties of Bovine Serum Albumin by Covalent Attachment of Polyethylene Glycol" J. Biol. Chem. 252:3578-3581 (1977). Braun et al., Biochim. Acta 44:143 (1985). Chang, "Microencapsulation and Artificial Cells" Humana Press, Clifton, NJ, pp. 4-26 (1984). Darquy and Reach "Immunoisolation of pancreatic B cells by microencapsulation" Diabetologia 28:776-780 (1985). Decker and Moussa, Macromolecules 22:4455. Desai and Hubbell "Solution technique to incorporate polyethylene oxide and other water-soluble polymers into surfaces of polymeric biomaterials" Biomaterials 12:144-153 (1991). Dupuy et al., "Agarose Beads in Paraffin Oil as Interfaces to Encapsulate Living Cells. Tests of function with Islets of Langerhans" Artif. Organs 11:314 (1987). Dupuy et al., In situ polymerization of a microencapsulating medium round living cells Journal of Biomedical Materials Research 22:1061-1070 (1988). Eaton, Advances in Photochemistry 13:427 (1986). Gharapetian et al., "Encapsulation of Viable Cells Within Polyacrylate Membranes" Biotech. Bioeng. 28:1595-1600 (1986). Goosen et al., "Optimization of Microencapsulation Parameters: Semipermeable Microcapsules as a Bioartificial Pancreas" Biotechnol. Bioeng. 27:146-150 (1985). Harris, J. Milton, "Laboratory Synthesis of Polyethylene Glycol Derivatives" JMS-Rev. Macromol. Chem. Phys. C25(3):325-373 (1985). Harris et al., J. Polym. Sci., Polym. Chem. Ed. 22:341 (1984). Hoyle et al., "Laser-Pulsed Photopolymerization of Methyl Methacrylate: The Effect of Repetition Rate" Macromolecules 22:3866-3871 (1989). Iwata et al., "Evaluation of Microencapsulated Islets in Agarose Gel as Bioartificial Pancreas by Studies of Hormone Secretion in Cultrue and by Xenotransplantation" Diabetes 38(1):224-225 (1989). Karu, T. I., "Effects Of Visible Radiation On Cultured Cells" Photochem. and Photobiol. 52:1089-1098 (1990). Lanza et al., "Large-Scale Canine and Human Islet Isolation Using a Physiological Islet Purification Solution" Diabetes 39:309A (1990). Lim and Sun, "Microencapsulated Islets as Bioartificial Endocrine Pancreas" Science 210:908-910 (1980). Mathias et al., J. Polym. Sci., Polym. Lett. Ed. 20:473 (1982). Moe et al., Food Hydrocolloids 5:119 (1991). Morrison and Boyd, Organic Chemistry, Allyn and Bacon, p. 755 (1973). Pitha et al., "Detergents Linked to Polysaccharides: Preparation and Effects on Membranes and Cells" Eur. J. Biochem. 94:11-18 (1979). Sefton et al., "HEMA-MMA Copolymer For The Microencapsulation Of Mammalian Cells" Polymer Preprints 31:217-218 (1990). Smidsrod and Skjak-Braek, "Alginate as immobilization matrix for cells" Trends in Biotechnology 8:71-78 (1990). Soon-Shiong et al., "Islet Purification by a Novel Immunomicrosphere Cell Depletion Technique" Transplantation Proceedings 22(2):780-781 (1990). Soon-Shiong et al., "An Immunologic Basis for the Fibrotic Reaction to Implanted Microcapsules" Transplantation Proceedings 23(1):758-759 (1991). Wu, Laser Focus World, Nov. 1990, p. 99 (1990).
Patent History
Patent number: 5837747
Type: Grant
Filed: Apr 28, 1994
Date of Patent: Nov 17, 1998
Assignee: VivoRx, Inc. (Santa Monica, CA)
Inventors: Patrick Soon-Shiong (Los Angeles, CA), Neil P. Desai (Los Angeles, CA), Paul A. Sandford (Los Angeles, CA), Roswitha A. Heintz (Los Angeles, CA), Soebianto Sojomihardjo (Pasadena, CA)
Primary Examiner: Susan W. Berman
Attorneys: Stephen E. Gray Cary Ware & Freidenrich Reiter, Gregory P. Raymer
Application Number: 8/232,054